METEORIC-HF
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance
- Stadium
- klaar
- Middel
- Omecamtiv Mecarbil
- Populatie
- Hartfalen
- Fase
- III
- First Patient In
- 9 juli 2020
- Last Patient In
- 8 juni 2021
- Last Patient Last Visit
- 30 november 2021